Intrinsic Value of S&P & Nasdaq Contact Us

Gritstone bio, Inc. GRTS

NASDAQ Global Select

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.67
+14403.1%

Gritstone bio, Inc. (GRTS) current share price is $0.03. The gold spot price is $4,825.20 per troy ounce. Using the formula: GRTS in gold = $0.03 × 31.1035 ÷ $4,825.20 = 0.0002 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of GRTS when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding GRTS shares over the measured period.

GRTS in US Dollars
Gold in US Dollars
GRTS in Gold (grams per share)

Real Wealth Growth Rate

GRTS
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{GRTS}_{\text{gold}}(t) = \frac{P_{\text{GRTS}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{GRTS}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{GRTS}_{\text{gold}}^{(T)}}{\text{GRTS}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{GRTS}_\text{gold}^{(0)}$ = initial gold-price, $\text{GRTS}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

BBIO
BBIO
BridgeBio Pharma, Inc.
$77.70
-0.30%
IMGN
IMGN
ImmunoGen, Inc.
$31.24
+0.02%
ERAS
ERAS
Erasca, Inc.
$18.20
+1.96%
EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.70
+1.63%
AUPH
AUPH
Aurinia Pharmaceuticals Inc.
$16.05
-0.12%
CRVS
CRVS
Corvus Pharmaceuticals, Inc.
$15.11
-0.92%
ANNX
ANNX
Annexon, Inc.
$6.35
+9.48%
ALLO
ALLO
Allogene Therapeutics, Inc.
$2.17
-4.82%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message